Lars D. Engstrom
Lars D. Engstrom publishes mostly in Molecular Biology, Oncology and Pulmonary and Respiratory Medicine, on topics such as Cancer-related gene regulation, Lung Cancer Treatments and Mutations and Cancer therapeutics and mechanisms.
- World rank
- #168,389 of 7,710,434 ranked researchers
- Rank in United States
- #63,068 of 1,627,098
- Works
- 183
- Citations
- 4.6k
- Citations per work
- 25.0
What does Lars D. Engstrom research?
Lars D. Engstrom's work is mostly in Biochemistry, Genetics and Molecular Biology (44%), Medicine (36%), Chemistry (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences8144.1%
- Health Sciences6636.0%
- Medicine6636.0%
- Everything else3016.2%
- Physical Sciences73.7%
- Chemistry73.7%
- 1Molecular Biology42% of their works
- 2Oncology19% of their works
- 3Pulmonary and Respiratory Medicine14% of their works
- 4Organic Chemistry4% of their works
- 5Hepatology3% of their works
- 6Cancer Research2% of their works
Research topics
Which keywords describe Lars D. Engstrom's research?
The keywords of their largest research topics: Cancer, Clinical Trials, Targeted Therapy, Chemotherapy, ALK Inhibitors, Arginine Methylation, EGFR Mutations and Protein Arginine Methyltransferases.
- Ubiquitin
- Nucleotide Metabolism
- mTOR
- Small-Cell Lung Cancer
- KRAS Mutations
- DNA
- Protein Arginine Methyltransferases
- Arginine Methylation
- Chemotherapy
- Clinical Trials
- Cancer
- Targeted Therapy
- ALK Inhibitors
- EGFR Mutations
- Cetuximab
- Genomic Profiles
- Signaling
- Topoisomerases
- Enzyme Regulation
- Proteasome
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Cancer192 topics
- Clinical Trials192 topics
- Targeted Therapy192 topics
- Chemotherapy183 topics
- ALK Inhibitors131 topic
- Arginine Methylation131 topic
- EGFR Mutations131 topic
- Protein Arginine Methyltransferases131 topic
- Cetuximab61 topic
- DNA61 topic
- Genomic Profiles61 topic
- KRAS Mutations61 topic
- Signaling61 topic
- Small-Cell Lung Cancer61 topic
- Topoisomerases61 topic
- mTOR61 topic
- Enzyme Regulation41 topic
- Nucleotide Metabolism41 topic
- Proteasome41 topic
- Ubiquitin41 topic
Where does Lars D. Engstrom work?
Lars D. Engstrom's main affiliation in the publication record is Mirati Therapeutics (United States), United States.
How many publications and citations does Lars D. Engstrom have?
OpenAlex counts 183 works and 4,582 citations for Lars D. Engstrom, an h-index of 18, ranking #168,389 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Lars D. Engstrom. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.